FENOBAM
Fenobam is an mGluR5 antagonist investigated for anxiety and fragile X syndrome. Side effects include dizziness, headaches, and mild gastrointestinal discomfort.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
This compound (ID 26117) acts through multi-pathway biochemical modulation, influencing cellular signalling, enzyme regulation, and structural protein dynamics. Its mechanistic profile includes receptor-level interactions, post‑translational modification control and targeted metabolic pathway influence.
Benefits and Advantages
Applications include advanced research modelling, pathway‑specific modulation, validation of pharmacodynamic targets, and high-precision experimental development in biochemical and clinical pre‑formulation environments.
Side Effects and Risks
Potential risks may include cellular stress responses, metabolic burden imbalance, receptor overstimulation or suppression, and dose‑dependent toxicity. Use under controlled laboratory conditions only.
Datasheet
| Molecular Formula | C13H10N2O2 |
|---|---|
| Molecular Weight | 266.68 g/mol |
| CAS Number | 57653-26-6 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Fenobam; 57653-26-6; fenobam anhydrous; 3-(3-chlorophenyl)-1-(1-methyl-4-oxo-5H-imidazol-2-yl)urea; NPL2009 |
| IUPAC/Chemical Name | 1-(3-chlorophenyl)-3-(1-methyl-4-oxoimidazolidin-2-ylidene)urea |
| InChl Key | DWPQODZAOSWNHB-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
